Skip to main content
Clinical Trials/NCT06680518
NCT06680518
Recruiting
Not Applicable

Prospective, Randomized Study of Tourniquet Use in Hallux Valgus Surgery

Clinique Saint Jean, France1 site in 1 country44 target enrollmentOctober 9, 2024
ConditionsHallux Valgus

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hallux Valgus
Sponsor
Clinique Saint Jean, France
Enrollment
44
Locations
1
Primary Endpoint
Average pain in the first week after surgery
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

Prospective, single-center, randomized interventional clinical trial of tourniquet use in hallux valgus surgery. Patients will be their own controls.

Registry
clinicaltrials.gov
Start Date
October 9, 2024
End Date
April 1, 2026
Last Updated
5 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Clinique Saint Jean, France
Responsible Party
Principal Investigator
Principal Investigator

Wayan HEBRARD

Doctor

Clinique Saint Jean, France

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 who has been informed and has signed the consent form
  • Patient to be operated on for bilateral hallux valgus with no difference in the procedure performed between the 2 feet, the deformity must not differ by more than 10° (angle M1P1) between the 2 sides.
  • Surgery planned on the same day for both feet

Exclusion Criteria

  • Arthritic hallux valgus requiring arthrodesis
  • Inflammatory pathology (rheumatoid arthritis, etc.)

Outcomes

Primary Outcomes

Average pain in the first week after surgery

Time Frame: first week after surgery

Comparison between the 2 groups of the average VAS over the first week following surgery, from 0 to 100 points, 0 being the value where the patient has no pain and 100 the maximum pain value.

Secondary Outcomes

  • Edema(Day 10 after surgery)
  • Complications(first week after surgery)

Study Sites (1)

Loading locations...

Similar Trials